Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
AMAZE HOLDINGS INC (AMZE)
AMEXInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$0.010.00%
Close 2026-10-26 · 1-day change
AMEXInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.32 → 2.32 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AMZE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Operating income improves from -$5.3 million | A primary condition in AMAZE HOLDINGS INC's published investment case. The stated target is Operating income better than -$5.3 million in 2026-Q1. | Broken | Operating income worsens beyond -$5.3 million in 2026-Q1 | Operating income: $-4.666M FY2026-Q2; GAAP. Published target: Operating income better than -$5.3 million in 2026-Q1. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 14, 2026-4,665,779 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
AMZE is a high-risk, speculative growth business rather than an established compounder. Its long-term thesis is in watch status, with recent momentum improving but financial performance still below its industry cohort.
The valuation evidence is mixed: one measure says AMZE is cheap versus peers, while another indicates a small premium, and confidence in the valuation model is low. The expectations gap is negative, but the available evidence does not show precisely what assumptions the market has already priced in.
Near term, repeated recent earnings misses and an elevated risk of another miss leave execution under pressure. Momentum improved, and the C2 Live investment adds a growth initiative, but it has no earlier quarters for comparison; the interim CEO transition and recent listing notice add uncertainty.
The multi-year thesis hinges on whether management can execute its strategy and improve cost and revenue performance. A guidance cut would be a negative signal, while lower interest rates and stabilization among major technology companies could support the sector backdrop.
Over the next one to three years, AMZE’s case depends on turning new initiatives and improved momentum into sustained financial progress, while managing leadership, earnings, and listing risks. Evidence remains limited and confidence is medium. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Revenue reaches $6 million in FY26 | A primary condition in AMAZE HOLDINGS INC's published investment case. The stated target is 6.0 USD_MILLIONS. | Intact | Revenue falls below $6 million in FY26 | Revenue: $619,621 FY2026-Q2; GAAP. Published target: 6.0 USD_MILLIONS. Target period ends 2026-12-31; this observation covers 2026-Q2. Aug 14, 2026619,621 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Leverage strategic partnership with LA Times Studios | Amaze Holdings has a strategic partnership with LA Times Studios to grow content. | Under Pressure | No meaningful progress or announcements on partnership by end 2026 | No partnership announcements vs target by 2026-12-31 No partnership news; delisting notice, $100M equity sale, and stock at $0.01 indicate stalled turnaround. Oct 26, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.29 → $2.32 · observed estimates
$0.02B → $0.02B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.29 | $21,250,000 | 1 / 1 |
| 2026-07-25 | $0.29 | $21,250,000 | 1 / 1 |
| 2026-07-26 | $0.29 | $21,250,000 | 1 / 1 |
| 2026-07-27 | $0.29 | $21,250,000 | 1 / 1 |
| 2026-07-28 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-07-29 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-07-30 | $0.29 | Unavailable | 1 / 0 |
| 2026-07-31 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-01 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-02 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-03 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-04 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-05 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-06 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-07 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-08 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-09 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-10 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-11 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-12 | $0.29 | Unavailable | 1 / 0 |
| 2026-08-13 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-14 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-15 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-16 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-17 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-18 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-19 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-20 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-21 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-22 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-23 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-24 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-25 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-26 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-27 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-28 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-29 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-30 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-08-31 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-01 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-02 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-03 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-04 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-05 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-06 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-07 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-08 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-09 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-10 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-11 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-12 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-13 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-14 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-15 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-16 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-17 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-18 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-19 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-20 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-21 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-22 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-23 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-24 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-25 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-26 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-27 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-28 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-29 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-09-30 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-01 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-02 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-03 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-04 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-05 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-06 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-07 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-08 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-09 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-10 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-11 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-12 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-13 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-14 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-15 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-16 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-17 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-18 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-19 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-20 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-21 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-22 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-23 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-24 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-25 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-26 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-27 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-28 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-29 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-30 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-10-31 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-11-01 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-11-02 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-11-03 | $2.32 | $21,250,000 | 1 / 1 |
| 2026-11-04 | $2.32 | $21,250,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.